These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 26812174

  • 1. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM, Sen K, Weigand MR, Skoff TH, Cunningham VA, Halse TA, Tondella ML, CDC Pertussis Working Group.
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [Abstract] [Full Text] [Related]

  • 2. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.
    Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M.
    Clin Vaccine Immunol; 2010 May; 17(5):807-12. PubMed ID: 20357056
    [Abstract] [Full Text] [Related]

  • 3. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, Lawrence A, Robson J, Hogg G, Lan R.
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [Abstract] [Full Text] [Related]

  • 4. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
    Shinkarev AS, Mertsalova NU, Mazurova IK, Borisova OIu, Zakharova NS, Ozeretskovskaia MN, Zaĭtsev EM, Poddubikov AV, Britsina MV, Bazhanova IG.
    Zh Mikrobiol Epidemiol Immunobiol; 2007 Apr; (4):20-5. PubMed ID: 17886371
    [Abstract] [Full Text] [Related]

  • 5. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N, Guiso N.
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [Abstract] [Full Text] [Related]

  • 6. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
    Carriquiriborde F, Regidor V, Aispuro PM, Magali G, Bartel E, Bottero D, Hozbor D.
    Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
    [Abstract] [Full Text] [Related]

  • 7. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z, Octavia S, Luu LDW, Payne M, Timms V, Tay CY, Keil AD, Sintchenko V, Guiso N, Lan R.
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [Abstract] [Full Text] [Related]

  • 8. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?].
    Zavadilová J, Lžičařová D, Musílek M, Křížová P, Fabiánová K.
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
    Gzyl A, Augustynowicz E, Zawadka M, Rabczenko D, Slusarczyk J.
    Med Dosw Mikrobiol; 2007 Sep; 59(2):123-35. PubMed ID: 17929410
    [Abstract] [Full Text] [Related]

  • 10. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T, Musser KA, Currenti SA, Zansky SM, Halse TA.
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [Abstract] [Full Text] [Related]

  • 11. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N, Dore G, Guiso N.
    Vaccine; 2014 Nov 20; 32(49):6597-600. PubMed ID: 25312274
    [Abstract] [Full Text] [Related]

  • 12. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.
    Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q.
    Euro Surveill; 2019 Feb 20; 24(7):. PubMed ID: 30782265
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
    Byrne S, Slack AT.
    BMC Infect Dis; 2006 Mar 16; 6():53. PubMed ID: 16542440
    [Abstract] [Full Text] [Related]

  • 14. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W, Impoolsup A, Boonchird C, Luengchaichawange A, Prompiboon P, Petre J, Panbangred W.
    BMC Microbiol; 2012 Apr 23; 12():61. PubMed ID: 22524455
    [Abstract] [Full Text] [Related]

  • 15. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA.
    Clin Infect Dis; 2015 Jan 15; 60(2):223-7. PubMed ID: 25301209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
    Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N.
    Vaccine; 2009 Oct 09; 27(43):6034-41. PubMed ID: 19666155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.